SG Americas Securities’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,993
Closed -$212K 3399
2026
Q1
$212K Sell
5,993
-6,883
-53% -$280K ﹤0.01% 2606
2025
Q4
$523K Sell
12,876
-51,018
-80% -$2.22M ﹤0.01% 2463
2025
Q3
$3M Buy
63,894
+61,860
+3,041% +$3.21M 0.01% 734
2025
Q2
$106K Sell
2,034
-2,298
-53% -$126K ﹤0.01% 2614
2025
Q1
$262K Buy
+4,332
New +$279K ﹤0.01% 2326
2024
Q4
Sell
-10,924
Closed -$786K 3205
2024
Q3
$786K Buy
10,924
+5,903
+118% +$417K ﹤0.01% 1282
2024
Q2
$348K Buy
5,021
+2,601
+107% +$190K ﹤0.01% 1885
2024
Q1
$194K Sell
2,420
-622
-20% -$55.4K ﹤0.01% 1995
2023
Q4
$333K Sell
3,042
-20,630
-87% -$2.13M ﹤0.01% 1744
2023
Q3
$2.39M Buy
+23,672
New +$2.72M 0.03% 623
2023
Q2
Sell
-10,298
Closed -$1.07M 2431
2023
Q1
$1.07M Buy
10,298
+1,154
+13% +$112K 0.01% 1096
2022
Q4
$811K Sell
9,144
-3,980
-30% -$330K 0.01% 1112
2022
Q3
$1.05M Buy
13,124
+1,362
+12% +$128K 0.01% 981
2022
Q2
$1.13M Buy
11,762
+9,034
+331% +$1.08M 0.01% 1202
2022
Q1
$405K Buy
+2,728
New +$381K ﹤0.01% 2015
2021
Q4
Sell
-19,445
Closed -$2.54M 3436
2021
Q3
$2.54M Sell
19,445
-7,332
-27% -$959K 0.01% 1057
2021
Q2
$3.68M Buy
26,777
+24,851
+1,290% +$3.4M 0.02% 757
2021
Q1
$252K Buy
+1,926
New +$232K ﹤0.01% 2514
2020
Q3
Sell
-3,770
Closed -$271K 2818
2020
Q2
$271K Sell
3,770
-73,857
-95% -$5.14M ﹤0.01% 2590
2020
Q1
$4.45M Buy
77,627
+60,521
+354% +$5.58M 0.04% 423
2019
Q4
$1.91M Buy
17,106
+4,511
+36% +$481K 0.02% 847
2019
Q3
$1.21M Sell
12,595
-4,935
-28% -$463K 0.01% 1280
2019
Q2
$1.5M Buy
17,530
+16,235
+1,254% +$1.33M 0.01% 1189
2019
Q1
$108K Sell
1,295
-10,862
-89% -$789K ﹤0.01% 3016
2018
Q4
$780K Buy
12,157
+4,490
+59% +$307K 0.01% 1535
2018
Q3
$607K Sell
7,667
-868
-10% -$67.1K ﹤0.01% 2015
2018
Q2
$625K Buy
8,535
+4,980
+140% +$339K 0.01% 1832
2018
Q1
$225K Sell
3,555
-3,542
-50% -$211K ﹤0.01% 2354
2017
Q4
$362K Sell
7,097
-1,919
-21% -$99.9K ﹤0.01% 2051
2017
Q3
$473K Buy
9,016
+6,839
+314% +$343K ﹤0.01% 1891
2017
Q2
$111K Buy
+2,177
New +$108K ﹤0.01% 2842
2016
Q4
Sell
-4,318
Closed -$173K 3155
2016
Q3
$173K Buy
+4,318
New +$183K ﹤0.01% 2615
2016
Q2
Sell
-2,816
Closed -$118K 2656
2016
Q1
$118K Buy
+2,816
New +$111K ﹤0.01% 2528
2015
Q4
Sell
-2,644
Closed -$126K 2731
2015
Q3
$126K Buy
2,644
+172
+7% +$9.44K ﹤0.01% 1726
2015
Q2
$144K Buy
+2,472
New +$133K ﹤0.01% 2153
2015
Q1
Sell
-5,912
Closed -$266K 2595
2014
Q4
$266K Buy
+5,912
New +$248K ﹤0.01% 2170
2013
Q4
Sell
-4,578
Closed -$156K 2699
2013
Q3
$156K Buy
+4,578
New +$149K ﹤0.01% 2359

Other funds holding CNMD

SG Americas Securities's CNMD Position: Q2 2026 in Review

SG Americas Securities sold out of CONMED (CNMD) in Q2 2026, closing a stake of 5,993 shares — an estimated $212K sold.

SG Americas Securities first reported a position in CNMD in Q3 2013 and held it in 37 quarters. The position peaked at $4.45M in Q1 2020. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • SG Americas Securities reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 5,993 CONMED shares in Q2 2026, an estimated $212K.
  • SG Americas Securities first reported a position in CONMED in Q3 2013 and held it in 37 quarters.
  • SG Americas Securities's CONMED position peaked at $4.45M in Q1 2020.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.